×

Preclinical Imaging Market

Preclinical Imaging Market Outlook, 2023- Forecasts and Opportunities in the Preclinical Imaging Industry by Type (Devices, Reagents, Services), Technologies (Optical Imaging, Micro MRI, Micro PET, SPECT, Micro Ultrasound, Micro CT, Photoacoustic (PAT) Imaging, Others), Companies and Countries to 2030

  • Home
  • Healthcare
  • Preclinical Imaging Market
  • |Published Month : December, 2022
  • |No. of Pages : 180

The use of preclinical imaging for a wide range of applications is supporting the rapid market growth across markets. The market report analyzes the devices, reagents, and services offered in preclinical imaging. Further, the market outlook for different technologies including Optical Imaging, Micro MRI, Micro PET, SPECT, Micro Ultrasound, Micro CT, Photoacoustic (PAT) Imaging, and others is provided across the globe and five regions. The leading companies offering preclinical imaging equipment, consumables, and services are also profiled in the industry study.

Preclinical Imaging Market Study Highlights, 2023

  • The global Preclinical Imaging Market Size stood at US$2.1 Billion in 2022 and is poised to register 7.88% growth over the forecast period from 2023 to 2030
  • Preclinical Imaging Devices are the largest type of Preclinical Imaging with a 72% market share. Other key types of Preclinical Imaging analyzed in the report include reagents and services.  
  • Among different equipment types, optical imaging remains the dominant type of Preclinical Imaging in value terms, with the highest market share in 2022. Other equipment types of Preclinical Imaging include Micro MRI, Micro PET, SPECT, Micro Ultrasound, Micro CT, Photoacoustic (PAT) Imaging, and Others.
  • Driven by rapid adoption across pharmaceutical research companies, North America dominates the global Preclinical Imaging market with the dominant market share in value terms.
  • Key market driving forces include Increased R&D in Pharmaceutical Companies, preference for Noninvasive Small-Animal Imaging Techniques, Use of preclinical imaging modalities for the detection of neurological diseases, ongoing demand for Multi-modality Imaging Systems, Advances in PET Technology, Preclinical Imaging solutions - outsourcing CRO opportunities and others are identified among main market dynamics
  • On the other hand, challenges associated with High Costs associated with equipment and reagents, Strict Regulations Governing Preclinical Research, Lack of trained personnel, and the negative impact of COVID-19 restrict the market growth
  • The market is highly fragmented in nature with intense competitive conditions among leading market players. Intense competitive conditions exist among large conglomerates, resulting in increased mergers and acquisitions activities.

 

Preclinical Imaging Market Outlook to 2030

Preclinical Imaging Market Outlook to 2030

Preclinical Imaging Market Overview

Preclinical Imaging is one of the fastest-growing markets in the pharmaceutical industry, with rapid adoption across developing and developed markets. Technological advancements in the industry are encouraging the wide adoption of different devices, reagents, and services. Key advantages of Preclinical Imaging such as the non-invasive nature of the tools, positive impact on animal protection, and high-resolution images support the market growth. A wide variety of imaging modalities including MRI, CT, PET, SPECT, and others are witnessing market demand.

A shifting market trend towards multimodality preclinical imaging technologies is observed as companies emphasize achieving high-quality and efficient data on small animals and rodents. Both large-scale users and small/medium-scale companies are relying on multimodality tools for their drug discovery applications.

The market growth is driven by Increased R&D in Pharmaceutical Companies, preference for Non-invasive Small-Animal Imaging Techniques, Use of preclinical imaging modalities for the detection of neurological diseases, ongoing demand for Multi-modality Imaging Systems, Advances in PET Technology, Preclinical Imaging solutions - outsourcing CRO opportunities and others and other driving forces. On the other hand, challenges associated with the negative impact of COVID-19 conditions, higher costs, operational challenges, and others restrict market growth.

 

Preclinical Imaging Market Trend - Non-invasive Small-Animal Imaging Techniques

Non-invasive small animal imaging is quickly emerging as an important tool for gathering data to fuel drug development decisions across the pipeline development process. It allows companies to assess gross anatomical structures, and variations in molecular structure and function, attaining sensitivity and specificity for clinical and biomarker endpoints. They also support increasing the efficiency of lead candidate selection.

Non-invasive imaging in preclinical studies has been largely used for phenotyping transgenic animals using targeted probes. However, technological advancements are encouraging the use of new techniques such as magnetic resonance microscopy for reliable developmental toxicity, translation between preclinical testing, and clinical evaluation of drugs. A wide variety of imaging modalities including MRI, CT, PET, SPECT, and others are witnessing market demand.

Non-invasive in vivo molecular imaging in small animal models presents key advantages such as the ability to monitor intra-individual therapy, increase the significance of the results, rationalization of animal numbers, and imaging morphologic structures among others. This will fuel the investments in preclinical imaging equipment across companies.

 

Preclinical Imaging Market Opportunities- Advances in PET Technology

PET is one of the fastest-growing imaging modalities in the industry. Improvements in hardware, integration with advanced software systems, improved PET sensitivity, 3D imaging, and overall improved image quality and resolution are encouraging enhanced clinical utility of the technology.

Advancements in resolution and sensitivity, the use of continuous crystals for superior imaging capabilities, visualization and quantification of tumor features on a molecular level, and adoption across oncology and neurological conditions support the wide adoption of preclinical imaging systems.

Further, total body imaging is also possible, which enables researchers to understand the pharmacokinetics of pipeline candidates in all body organs. Integration with other imaging modalities is further strengthening the adoption of PET across applications. 

 

Preclinical Imaging Market Share Analysis- Optical Imaging generated the highest revenue in 2022

Optical imaging techniques play a predominant role in the preclinical imaging industry. It is a non-toxic and non-invasive imaging method and enables researchers to study cells and tissues in their original location without influencing interactions with the microenvironment. Clinicians are using optical technologies for molecular imaging in vivo scenarios to distinguish anatomic and molecular structures.

Further, with real-time imaging, the technology can offer more information on the target and can be very helpful in the investigation of cancer and other conditions, which supports the wide adoption of the technology.

Different types of optical imaging techniques including bioluminescence/Luminescence imaging, fluorescence imaging, optoacoustic, and others are widely used. Based on the required sensitivity, operational complexity levels, use of contrast agents, and other parameters, different optical imaging techniques are deployed for different applications. Cell viability and proliferation, oncology study, gene expression study, understanding protein-protein interaction, drug discovery, and development remain major applications of optical imaging.

Preclinical Imaging Market Share- Optical Imaging, Micro MRI, PET, SPECT, CT, PAT

In particular, bioluminescence imaging (BLI) is a widely used optical imaging technique in preclinical small animal studies, due to low cost, ease of operation, high sensitivity, and low background signal. It also allows the real-time study of biological processes. Optical fluorescence is also one of the largest used preclinical imaging technologies and requires light excitation of the fluorophore to produce light of lower energy. It does not require substrate and the image can be acquired within a few seconds.

The low-cost advantages of optical imaging coupled with low radioactivity, and high sensitivity enables its wide use in academic institutes, small to medium-scale companies, and other entities conducting preclinical research.

 

Preclinical Imaging Market Segmentation

Components

  • Devices
  • Reagents
  • Services

Types

  • Optical Imaging
  • Micro MRI
  • Micro PET, SPECT
  • Micro Ultrasound
  • Micro CT
  • Photoacoustic (PAT) Imaging
  • Others

Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Companies

  • Fujifilm Holdings Corporation
  • Li-COR, Inc.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Aspect Imaging Ltd.
  • Siemens AG
  • General Electric
  • TriFoil Imaging
  • Agilent Technologies
  • MILabs BV

1. Executive Summary

1.1 Introduction to Preclinical Imaging Markets

1.2 Preclinical Imaging Market Size Outlook, 2021- 2030

1.3 Growth Opportunities in Preclinical Imaging Industry

1.4 Winning Strategies for the post-pandemic future

 

2. Report Guide

2.1 Market Definition and Scope

2.2 Market Segmentation

2.3 Research Methodology

2.4 Forecast Methodology

2.5 List of Abbreviations

 

3. Growth Opportunity Analysis

3.1 Key Preclinical Imaging Market Trends

3.1.1 Increased R&D in Pharmaceutical Companies

3.1.2 Non-invasive Small-Animal Imaging Techniques

3.1.3 Use of preclinical imaging modalities for the detection of neurological diseases

 

3.2 Key Preclinical Imaging Market Growth Drivers

3.2.1 Advances in PET Technology

3.2.2 Preclinical Imaging solutions - outsourcing CRO opportunities

3.2.3 Increasing global Healthcare Expenditure worldwide

 

3.3 Key Preclinical Imaging Market Growth Restraints

3.3.1 High Costs associated with equipment and reagents

3.3.2 Strict Regulations Governing Preclinical Research

 

4 Preclinical Imaging Market Outlook – Scenario Analysis

4.1 Low Growth Case Scenario Forecasts: Preclinical Imaging Market Size Outlook to 2030

4.2 Reference Growth Case Scenario Forecasts: Preclinical Imaging Market Size Outlook to 2030

4.3 High Growth Case Scenario Forecasts: Preclinical Imaging Market Size Outlook to 2030

 

5. Preclinical Imaging Market Segmentation- Outlook by Type

5.1 Preclinical Imaging Market Share Analysis by Type, 2023

5.2 Preclinical Imaging Devices Market Outlook to 2030

5.3 Preclinical Imaging Reagents Market Outlook to 2030

5.4 Preclinical Imaging Services Market Outlook to 2030

 

6. Preclinical Imaging Market Segmentation- Outlook by Technology

6.1 Preclinical Imaging Market Share Analysis by Technology, 2023

6.2 Optical Imaging: Preclinical Imaging Market Outlook to 2030

6.3 Micro MRI: Preclinical Imaging Market Outlook to 2030

6.4 Micro PET, SPECT: Preclinical Imaging Market Outlook to 2030

6.5 Micro Ultrasound: Preclinical Imaging Market Outlook to 2030

6.6 Micro CT: Preclinical Imaging Market Outlook to 2030

6.7 Photoacoustic (PAT) Imaging: Preclinical Imaging Market Outlook to 2030

6.8 Others: Preclinical Imaging Market Outlook to 2030

 

7. North America Preclinical Imaging Market Outlook and Opportunities to 2030

7.1 Market Snapshot, 2023

7.2 North America Preclinical Imaging Market Growth Opportunities

7.2.1 North America Preclinical Imaging Market Outlook by Type, 2021 to 2030

7.2.2 North America Preclinical Imaging Market Outlook by Application, 2021 to 2030

7.2.3 North America Preclinical Imaging Market Outlook by Country, 2021 to 2030

7.3 United States Preclinical Imaging Market Outlook, 2021 to 2030

7.4 Canada Preclinical Imaging Market Outlook, 2021 to 2030

7.5 Mexico Preclinical Imaging Market Outlook, 2021 to 2030

 

8. Europe Preclinical Imaging Market Outlook and Opportunities to 2030

8.1 Market Snapshot, 2023

8.2 Europe Preclinical Imaging Market Growth Opportunities

8.2.1 Europe Preclinical Imaging Market Outlook by Type, 2021 to 2030

8.2.2 Europe Preclinical Imaging Market Outlook by Application, 2021 to 2030

8.2.3 Europe Preclinical Imaging Market Outlook by Country, 2021 to 2030

8.3 Germany Preclinical Imaging Market Outlook, 2021 to 2030

8.4 France Preclinical Imaging Market Outlook, 2021 to 2030

8.5 United Kingdom Preclinical Imaging Market Outlook, 2021 to 2030

8.6 Spain Preclinical Imaging Market Outlook, 2021 to 2030

8.7 Italy Preclinical Imaging Market Outlook, 2021 to 2030

8.8 Other Europe Preclinical Imaging Market Outlook, 2021 to 2030

 

9. Asia Pacific Preclinical Imaging Market Outlook and Opportunities to 2030

9.1 Market Snapshot, 2023

9.2 Asia Pacific Preclinical Imaging Market Growth Opportunities

9.2.1 Asia Pacific Preclinical Imaging Market Outlook by Type, 2021 to 2030

9.2.2 Asia Pacific Preclinical Imaging Market Outlook by Application, 2021 to 2030

9.2.3 Asia Pacific Preclinical Imaging Market Outlook by Country, 2021 to 2030

9.3 China Preclinical Imaging Market Outlook, 2021 to 2030

9.4 Japan Preclinical Imaging Market Outlook, 2021 to 2030

9.5 India Preclinical Imaging Market Outlook, 2021 to 2030

9.6 South Korea Preclinical Imaging Market Outlook, 2021 to 2030

9.7 Indonesia Preclinical Imaging Market Outlook, 2021 to 2030

9.8 Other Asia Pacific Preclinical Imaging Market Outlook, 2021 to 2030

 

10. South and Central America Preclinical Imaging Market Outlook and Opportunities to 2030

10.1 Market Snapshot, 2023

10.2 South and Central America Preclinical Imaging Market Growth Opportunities

10.2.1 South and Central America Preclinical Imaging Market Outlook by Type, 2021 to 2030

10.2.2 South and Central America Preclinical Imaging Market Outlook by Application, 2021 to 2030

10.2.3 South and Central America Preclinical Imaging Market Outlook by Country, 2021 to 2030

10.3 Brazil Preclinical Imaging Market Outlook, 2021 to 2030

10.4 Argentina Preclinical Imaging Market Outlook, 2021 to 2030

10.5 Other Latin America Preclinical Imaging Market Outlook, 2021 to 2030

 

11. Middle East and Africa Preclinical Imaging Market Outlook and Opportunities to 2030

11.1 Market Snapshot, 2023

11.2 Middle East and Africa Preclinical Imaging Market Growth Opportunities

11.2.1 Middle East and Africa Preclinical Imaging Market Outlook by Type, 2021 to 2030

11.2.2 Middle East and Africa Preclinical Imaging Market Outlook by Application, 2021 to 2030

11.2.3 Middle East and Africa Preclinical Imaging Market Outlook by Country, 2021 to 2030

11.3 Saudi Arabia Preclinical Imaging Market Outlook, 2021 to 2030

11.4 United Arab Emirates (the UAE) Preclinical Imaging Market Outlook, 2021 to 2030

11.5 Other Middle East Preclinical Imaging Market Outlook, 2021 to 2030

11.6 Egypt Preclinical Imaging Market Outlook, 2021 to 2030

11.7 South Africa Preclinical Imaging Market Outlook, 2021 to 2030

11.8 Other Africa Preclinical Imaging Market Outlook, 2021 to 2030

 

12. Profiles of major world Preclinical Imaging Companies

12.1 Fujifilm Holdings Corporation

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.2 Li-COR, Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.3 PerkinElmer, Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.4 Bruker Corporation

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.5 Aspect Imaging Ltd.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.6 Siemens AG

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.7 General Electric

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

12.8 TriFoil Imaging

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

12.9 Agilent Technologies

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

12.10 MILabs BV

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

 

13. Appendix

13.1 Publisher’s Expertise

13.2 List of Tables and Charts

13.3 List of Exhibits

13.4 Legal Disclaimer                     

 

Sample Request

Frequently Asked Questions

Related Reports